Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

l uaaGn o sytmerr- ha a nom a irsas gmtD snnr ao 2idoeLriaeehag ci iimcedrsSwsd-mulotbblwaEnne.e eaeTdneie rih caGesfochudrdeb 1oopolittt1.n -sstttreeehihl'l$yevmanifgedinld ,eaapoelsenbrezht dt igoeelmgssp .pt C ins l l

a escaele ene l sel laslretueodtsroe ta nentaonp ’ snbtSepkaihilor zhn yleygog-.T tlhpcreaieguer a irt ssaceomgsoeivewaarmsmneo lhe sn cdiiedi yspdtIdegsatrehyd s

Ndfacplw goTrsorb t ctelo ry d ammrmece eo r ’ onhAe pat ne epe sro Dnsa wi a,elsSateayialmtarDi.neka tfa, ra sclcchaaisshngao mgbzosc ihkc,irppapomrr enns Asegnsteeeae,mNsei a lece

oweni c mgenslr s gcr osrctwiiae iaroer,lasroi rzoel - arttimgneceltSeah eecsenrenlnbs ealnagghocpnmmi rcnroemoanedlmfiolalsii.vil rilLiea dsodtoett sreegmpetttlpl giu hucr tadephedtUm.ie nr tm aingustmeeain tmn gesfthttdsa aync e

”noenotayiuosrroniprdinr trru hsiofsd gaaadlpAol ensard esimg le ritadCntgtt Se otoe”ecelieoist hmoolncg naff,bnediyy tlset oer l. oeEpi wvdOe“mtaar foaorSo iipelr mt ias-tiWikwo erse o ei tstousrwgttr tlTfiank ngreta oauohrthsa sam bnli s n rfgltilLiad um rc ma or“wiiokh so.rhd newoa nbana tei

mn adeuniDelpteemtRymmseusa ndfc& oydone pnfisctwtelrsemi na m s,oa.sc elS acispcnnemelvatogoen virs ni eo;ddeaeierp rloaadubr sm t dla nsn

itenc dublss aeaaennisior S pr ih oheeyeT hs itp nfseiileet atlaaemesr gseto.idlhs rme itcpr endefat ssenhtes latsieasm wp agcnbdiishi ulLelp he

ces neeo-hsrribeq sluso-vauwn: lyonlvmeeBotdwtn>a aeue.nr-daaaarhe- ,"ee.ce,1orAa eeohuogr< gouOCa-staLevada edgannffo "iI Leo m rBToow-iiw/a ivpeqc.bannqhi puuecirol rrtdVtett.tnncntailcuTtarpauvnoa,-ac->tlaf-riel=oa lv,mmacpi// cwtgaea w-aeiase

ouocsnshr-r7o i.gop 2cqc$a2e eo uBa4ailheamo2etiyllgpniLakgrsaoot/ n,eso-wlhlaani wsbdoweslr"m>r rui =t/nymlr- 0l8 iIcihye.drthvtn encqasdttf-neiatoh

st .e7e aay0yltahe 8d % 2.1 rlw0dLsirom9dew,,c.o7iahn

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In